Drug General Information
Drug ID
D0J0BU
Former ID
DNC009421
Drug Name
BETRIXABAN
Drug Type
Small molecular drug
Indication Venous thromboembolism [ICD9: 453; ICD10:I80-I82] Approved [889446]
Cerebrovascular ischaemia [ICD9: 434.91; ICD10:I61-I63] Phase 3 [523883]
Company
Portola Pharms
Structure
Download
2D MOL

3D MOL

Formula
C23H22ClN5O3
Canonical SMILES
CN(C)C(=N)C1=CC=C(C=C1)C(=O)NC2=C(C=C(C=C2)OC)C(=O)NC3=<br />NC=C(C=C3)Cl
InChI
1S/C23H22ClN5O3/c1-29(2)21(25)14-4-6-15(7-5-14)22(30)27-19-10-9-17(32-3)12-18(19)23(31)28-20-11-8-16(24)13-26-20/h4-13,25H,1-3H3,(H,27,30)(H,26,28,31)
InChIKey
XHOLNRLADUSQLD-UHFFFAOYSA-N
CAS Number
CAS 330942-05-7
PubChem Compound ID
Target and Pathway
Target(s) Coagulation factor Xa Target Info Modulator
KEGG Pathway Complement and coagulation cascades
PANTHER Pathway Blood coagulation
Pathway Interaction Database Beta2 integrin cell surface interactions
PathWhiz Pathway Coagulation
Reactome Extrinsic Pathway of Fibrin Clot Formation
Intrinsic Pathway of Fibrin Clot Formation
Common Pathway of Fibrin Clot Formation
Gamma-carboxylation of protein precursors
Transport of gamma-carboxylated protein precursors from the endoplasmic reticulum to the Golgi apparatus
Removal of aminoterminal propeptides from gamma-carboxylated proteins
WikiPathways Complement and Coagulation Cascades
Human Complement System
PTM: gamma carboxylation, hypusine formation and arylsulfatase activation
Blood Clotting Cascade
Formation of Fibrin Clot (Clotting Cascade)
References
Ref 523883ClinicalTrials.gov (NCT01583218) Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study). U.S. National Institutes of Health.
Ref 889446Drugs@FDA (Edaravone)

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.